相关实验视频
Updated: Jun 10, 2025
10:29
Generation of Human Chimeric Antigen Receptor Regulatory T Cells
Published on: January 3, 2025
1.2K
特定于MOG的CAR Tregs:一种用于治疗多发性硬化症的新方法
Jihane Frikeche1, Marion David1, Xavier Mouska1
1Research, Sangamo Therapeutics, Allée de la Nertière, Valbonne, 06560, France.
Journal of neuroinflammation
|October 20, 2024
概括
研究人员开发了一种新的化学抗原受体 (CAR) T细胞疗法,使用调节性T细胞 (Tregs) 向髓寡细胞糖蛋白 (MOG) 来治疗多发性硬化症 (MS). 这种MOG-CAR Treg疗法在诱导MS患者长期耐受性方面表现有前途.
科学领域:
- 免疫学 免疫学 免疫学
- 神经科学是一个神经科学.
- 细胞疗法细胞疗法
背景情况:
- 多发性硬化症 (MS) 是中枢神经系统 (CNS) 的一种慢性自身免疫性疾病,其特征是免疫介导的髓膜破坏和神经元损伤.
- 目前用于MS的疾病修饰疗法具有有限的疗效,并且不能阻止疾病的进展,因此需要制定个性化的长期治疗策略.
- 化学抗原受体 (CAR) T细胞疗法已成为癌症治疗的强大工具,提供高特异性和受控的细胞管理.
研究的目的:
- 通过工程调节性T细胞 (Tregs) 来适应CAR T细胞技术用于自身免疫性疾病,以诱导多发性硬化症患者的耐受性.
- 开发和评估一种特定于髓寡干细胞糖蛋白 (MOG) 的CAR Treg细胞疗法,作为对MS的潜在治疗方法.
- 在MS的临床前模型中评估MOG-CAR Tregs的功能,功效和疗效.
主要方法:
- 开发第二代CAR结构,其中包括从人类库中选的抗转基因单链可变片段 (scFv).
- 自主调节性T细胞 (Tregs) 的工程与MOG特定的CAR.
- 在实验室中对CAR依赖功能和体内疗效评估的鉴定,使用被动性自身免疫脑炎 (EAE) 实验小鼠模型.
主要成果:
- 在实验室中证明了MOG-CAR Tregs的CAR-依赖功能.
- 在临床前EAE小鼠模型中展示了MOG-CAR Tregs的显著疗效.
- 证实了低音调信号和良好的信号噪声比,表明一个非常强大的CAR结构.
结论:
- 开发的特定于MOG的CAR Treg细胞疗法代表了对多发性硬化症的一种有前途的新疗法.
- 这种CAR Treg策略有可能通过向关键的自身抗原,在MS患者中诱导长期耐受性.
- 对MOG-CAR Tregs的进一步调查可能会导致对MS的更个性化和更有效的长期治疗.
相关概念视频
01:24T Cell Types and Functions
955
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
955
01:27Tumor Immunotherapy
486
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486